Impact of Tumor Size on Probability of Pathologic Complete Response After Neoadjuvant Chemotherapy

BACKGROUND: The prospective Neoadjuvant Breast Symphony Trial (NBRST) study found that MammaPrint/BluePrint functional molecular subtype is superior to conventional immunohistochemistry/fluorescence in situ hybridization subtyping for predicting pathologic complete response (pCR) to neoadjuvant chem...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ann Surg Oncol
Main Authors: Baron, Paul, Beitsch, Peter, Boselli, Danielle, Symanowski, James, Pellicane, James V., Beatty, Jennifer, Richards, Paul, Mislowsky, Angela, Nash, Charles, Lee, Laura A., Murray, Mary, de Snoo, Femke A., Stork-Sloots, Lisette, Gittleman, Mark, Akbari, Stephanie, Whitworth, Pat
Formato: Artigo
Idioma:Inglês
Publicado em: Springer International Publishing 2015
Assuntos:
Breast Oncology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4819747/
https://ncbi.nlm.nih.gov/pubmed/26714960
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-015-5030-1
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados